Article

Role of SALL4 in hematopoiesis.

Department of Pathology, The State University of New York at Stony Brook, Stony Brook, New York, USA.
Current opinion in hematology (Impact Factor: 4.05). 05/2012; 19(4):287-91. DOI: 10.1097/MOH.0b013e328353c684
Source: PubMed

ABSTRACT Stem cell gene SALL4 has been well characterized for its essential role in developmental events as well as embryonic stem cell pluripotency maintenance. Several current reports now shed new light on its functions in regulating hematopoietic cell self-renewal and differentiation. In this review we attempt to summarize SALL4 roles for normal hematopoiesis, and how the knowledge obtained can be used to develop advanced cell therapies.
SALL4 may act as a critical controller to regulate the fate of hematopoietic cells. In normal bone marrow, SALL4 is selectively expressed in primitive hematopoietic precursors and rapidly downregulated following differentiation. Of particular interest, SALL4 isoforms are able to stimulate large scale ex-vivo expansion of hematopoietic stem/progenitor cells (HSCs/HPCs). The SALL4 expanded HSCs/HPCs retain multilineage repopulation and long-term engraftment activities, which are clinically meaningful. The stem cell self-renewal mediated by SALL4 is linked to epigenetic machinery.
The emerging knowledge about how SALL4 regulates HSC behavior may be used in the near future to develop advanced cell therapies, for example, through large-scale stem cell expansion ex vivo.

0 Followers
 · 
163 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: All-trans retinoic acid (ATRA) is a differentiation agent that revolutionized the treatment of acute promyelocytic leukemia (APL). However, it has not been useful for other types of AMLs. Here, we explored the effect of SALL4, a stem cell factor, on ATRA-induced cellular differentiation in both ATRA sensitive and resistant AML cells. Aberrant SALL4 expression has been found in nearly all human AML cases; while in normal bone marrow and peripheral blood cells, its expression is only restricted to hematopoietic stem/progenitor cells (HSPCs). We reason that in AMLs, SALL4 activation may prevent cell differentiation and/or protect self-renewal that is seen in normal HSPCs. Indeed, our studies show that ATRA-mediated myeloid differentiation can be largely blocked by exogenous expression of SALL4, while ATRA plus SALL4 knockdown causes significantly increased AML differentiation and cell death. Mechanistic studies indicate that SALL4 directly associates with RA receptor α (RARα) and modulates ATRA target gene expression. SALL4 is shown to recruit the lysine-specific histone demethylase 1 (LSD1) to target genes and alter the histone methylation status. Furthermore, co-inhibition of LSD1 and SALL4 plus ATRA treatment exhibited the strongest anti-AML effect. These findings suggest that SALL4 plays an unfavorable role in ATRA-based regimes, highlighting an important aspect of leukemia therapy. Copyright © 2015, The American Society for Biochemistry and Molecular Biology.
    Journal of Biological Chemistry 03/2015; 290(17). DOI:10.1074/jbc.M114.634790 · 4.60 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mouse embryonic stem cells (ESCs) are genetically more stable than somatic cells, thereby preventing the passage of genomic abnormalities to their derivatives including germ cells. The underlying mechanisms, however, remain largely unclear. In this paper, we show that the stemness factor Sall4 is required for activating the critical Ataxia Telangiectasia Mutated (ATM)-dependent cellular responses to DNA double-stranded breaks (DSBs) in mouse ESCs and confer their resistance to DSB-induced cytotoxicity. Sall4 is rapidly mobilized to the sites of DSBs after DNA damage. Furthermore, Sall4 interacts with Rad50 and stabilizes the Mre11-Rad50-Nbs1 complex for the efficient recruitment and activation of ATM. Sall4 also interacts with Baf60a, a member of the SWI/SNF (switch/sucrose nonfermentable) ATP-dependent chromatin-remodeling complex, which is responsible for recruiting Sall4 to the site of DNA DSB damage. Our findings provide novel mechanisms to coordinate stemness of ESCs with DNA damage response, ensuring genomic stability during the expansion of ESCs. © 2015 Xiong et al.
    The Journal of Cell Biology 03/2015; 208(5):513-520. DOI:10.1083/jcb.2085iti1 · 9.69 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This review presents a novel view and working hypothesis about the hierarchy within the adult bone marrow stem cell compartment and the still-intriguing question of whether adult bone marrow contains primitive stem cells from early embryonic development, such as cells derived from the epiblast, migrating primordial germ cells, or yolk sac-derived hemangioblasts. It also presents a novel view of the mechanisms that govern stem cell mobilization and homing, with special emphasis on the role of the complement cascade as a trigger for egress of hematopoietic stem cells from bone marrow into blood as well as the emerging role of novel homing factors and priming mechanisms that support stromal-derived factor 1 (SDF-1)-mediated homing of hematopoietic stem/progenitor cells after transplantation.Leukemia accepted article preview online, 09 December 2014. doi:10.1038/leu.2014.346.
    Leukemia 12/2014; DOI:10.1038/leu.2014.346 · 9.38 Impact Factor